Sipai Health Technology Co., Ltd. redeemed US$6,000,000 of a JPM wealth management product on November 20, 2026, generating US$343,200 in accrued interest. This follows an earlier redemption of US$8,000,000 in April 2026, bringing total accrued interest to US$621,600. The company stated the move is part of routine treasury management to support general working capital, with US$16,000,000 of the original investment remaining.
The company redeemed US$6,000,000 of a JPM wealth management product on November 20, 2026, earning US$343,200 in accrued interest, after an earlier US$8,000,000 redemption in April 2026 with US$278,400 interest. Aggregated redemptions exceed 5% of the percentage ratio, requiring only a discloseable-transaction announcement with no shareholder approval. This is routine treasury management: proceeds go to working capital and US$16,000,000 of the product remains, so no material change to the business outlook.
- • November 20, 2026 redemption of US$6,000,000 principal with US$343,200 accrued interest at a 4.09% annual rate
- • Only routine disclosure under HKEX Listing Rule 14.22; each redemption alone is below the 5% notifiable threshold
- • Gain or loss from the redemptions is still subject to auditor review